Pegargiminase Completed Phase 2 Trials for Acute Myeloid Leukemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01910012PH 2 ADI-PEG 20 Acute Myeloid Leukemia